Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
Effects Furosimide
|
-decrease BACKWARDS failure
-decrease blood volume--> decrease pulmonary congestion -decrease preload |
|
Risks w/ Furosimide
|
-hypokalemia- give w/ spirinolactone or eplepenone
-difficult to get into tubule w/ low GFR--> give frequent and high doses |
|
Effects of Spirinolactone and Eplerenone
|
-decrease BP (unknown mechanism)
-prevents remodeling of myocardium (block aldosterone) -prevents hyokalemia w/ furosimide |
|
Spirinolactone vs. Eplerenone
|
-Spirinolactone partial agonist for sex hormone receptors
-Eplerenone will not have sex hormone effects |
|
Enalapril
|
ACE (-)
-prevent myocardial remodeling -balanced vasodilation--> decrease preload--> helps FORWARD and BACKWARD failure -lower Filtration Fraction (increase RBF more than GFR) |
|
Lisinopril
|
ACE (-)
-prevent myocardial remodeling -balanced vasodilation--> decrease preload--> helps FORWARD and BACKWARD failure -lower Filtration Fraction (increase RBF more than GFR) |
|
Captopril
|
ACE (-)
-prevent myocardial remodeling -balanced vasodilation--> decrease preload--> helps FORWARD and BACKWARD failure -lower Filtration Fraction (increase RBF more than GFR) |
|
Why will Filtration Fraction fall w/ Captopril/ Lisinopril/ Enalapril?
|
ACE (-)
-a higher increase of RBF compared to GFR -will decrease diuresis |
|
Causes Balanced Vasodilation
|
ACE (-)- Captopril/ Enalapril/ Lisinopril
-decreased preload = venodilation -decreased afterload = arteriodilation ***helps FORWARD and BACKWARD failure*** -ALSO nitrates + hydralizine in black pts. |
|
Risks w/ ACE (-)
|
-myocardial hypoperfusion w/ lowered diastolic pressures
-hyperkalemia and uremia w/ poor renal function |
|
Nitrates + Hydralazine
|
-in black pts. will help increase BALANCED VASODILATION in conjunction w/ ACE (-)
-massive increase in survival -Nitrates = venodilation -Hydralazine = antioxidant preventing NO degredation |
|
Risks w/ Nitrates + Hydralazine
|
-prolonged Hydralizine--> SLE-like Sx in slow-acetylators
|
|
Carvedilol Function
|
Beta-antagonists- block beta and alpha 1 and 2 rec.
-prevents damage to heart w/ chronic sympathetic tone--> initial lower EF with eventual increase EF -prevents ventricular arrythmias |
|
Drug makes pt.s feel worse for months before they feel better:
|
Carvedilol
-initial decrease of EF w/ evential increase EF -start on dry weight w/ dose based on lean muscle mass -work-up to highest dose tolerated |
|
Blocks sympathetic tone:
|
Carvediol
-pts. feel worse for months before better -dose-dependant effects---> work up to highest tolerated -final increase in EF + prevents ventricular arrythmias -prolongs diastole |
|
Prolong diastole in Diastolic HF pts.
|
Carvediol
(blocks sympathetic tone- beta and alpha receptors) -eventual increase in EF -prolongs diastolic function -prevents ventricular arrythmias |
|
Digoxin MOA
|
Digoxin [=] Na/ K- ATPase (bind to Arg residue--> prevents action)
-Na/ Ca exchanger cannot work--> increased cytoplasmic Ca2++ -sarcolemmal increase in Ca-uptake--> INCREASED CONTRACTILITY -ALSO increases VAGAL TONE/ decrease sympathetic tone |
|
Digoxin Effects
|
-increase contractility
-increase vagal tone -decrease sympathetic tone |
|
Digoxin Risks
|
-narrow theraputic window
-hypokalemia and hypomagnesia will increase toxicity (beware when using furosimide) -premature ventricular contractions (in diastole) -abnormal yellow-green vision -Spirinolactone prevents clearance |
|
HF Digoxin interactions
|
-hypokalemia and magnesia will increase toxicity (helps bond to Asp residues--> common w/ furosemide)
-Spirinolactone will decrease clearance |